IXEMPRA

Swiss trademark · 526425 · Word mark · In force

Register entry

Registration number
526425
Application number
55477/2004
Status
In force
Type
Word mark
Filed
Aug 16, 2004
Registered
Oct 5, 2004
Published
Oct 19, 2004
Protected until
Aug 16, 2034
Priority
29.03.2004 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmaceutical preparations for human use

As filed

Pharmazeutische Präparate zur Anwendung beim Menschen.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 5, 2024

    Renewed

    Published in Swissreg on 05.07.2024

  2. May 17, 2016

    Transferred

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, NY 10154 New York, USA → R-PHARM US OPERATING, LLC, 3120 Princeton Pike, Suite 301, Lawrence, New Jersey 08648, USA
    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Dr. Michael Kikinis, Waffenplatzstrasse 10, 8002 Zürich

    Published in Swissreg on 17.05.2016

  3. Mar 5, 2014

    Renewed

    Published in Swissreg on 05.03.2014

  4. Dec 10, 2007

    Agent’s address changed

    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 239 of 10.12.2007

  5. Oct 19, 2004

    Registered

    Published in the SOGC no. 203 of 19.10.2004

Parties

Holder

R-PHARM US OPERATING, LLC

3120 Princeton Pike Suite 301, Lawrence, New Jersey 08648, US

Agent

Dr. Michael Kikinis

8002 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.